AbbVie, Inc. is a company in the U.S. stock market and it is a holding in 304 U.S.-traded ETFs. ABBV has around 145.2M shares in the U.S. ETF market. The largest ETF holder of ABBV is the SPDR S&P 500 ETF Trust (SPY), with approximately 18.76M shares. Investors may also find of interest that the ETF with the largest allocation to ABBV stock is First Trust Morningstar Dividend Leaders Index Fund (FDL), with a portfolio weight of 8.00%. On average, U.S. ETFs allocate 1.40% of ABBV to their portfolios.
Additionally, ABBV is a favorite stock for Active and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ABBV as a holding is the Leatherback Long/Short Alternative Yield ETF (LBAY), with a return of 19.06%.